PinnyPeptide

Epithalon vs NAD+ (Injectable)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Epithalon

Longevity

Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production.

Peptide B

NAD+ (Injectable)

Longevity

Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity.

Typical vial

10 mg

Typical dose

5000-10000 mcg

Half-life

~30 minutes (short half-life but biological effects persist due to gene expression changes)

FDA status

Not FDA approved for human use. No clinical trials submitted…

Typical vial

500 mg

Typical dose

50-200 mg (SubQ); 500-1500 mg (IV) mcg

Half-life

~6-10 hours (cellular turnover)

FDA status

Not FDA approved as a therapeutic. Available via compounding…

Epithalon effects

  • Activates telomerase enzyme to elongate telomeres
  • Restores melatonin production in the pineal gland
  • Regulates neuroendocrine function and circadian rhythms
  • Reduces incidence of spontaneous tumors in animal models
  • Modulates gene expression patterns associated with aging

NAD+ (Injectable) effects

  • Raises cellular NAD+ levels
  • Supports mitochondrial function via electron transport chain
  • Substrate for sirtuin enzymes (deacetylases linked to longevity)
  • Substrate for PARP enzymes (DNA repair)
  • Substrate for CD38 (immune signaling)
  • Subjective reports of energy, mental clarity, mood

Epithalon side effects

  • Mild injection site irritation
  • Occasional drowsiness (related to melatonin effects)
  • Rare mild headache
  • Transient changes in sleep patterns

NAD+ (Injectable) side effects

  • Flushing during IV infusion (most common, mild)
  • Nausea, chest pressure, abdominal discomfort with rapid infusion
  • Headache
  • Subcutaneous: injection-site irritation
  • Possible methylation depletion with chronic high doses

Epithalon dosing ranges

Anti-aging and telomere support

5-10 mg · Once daily (SubQ) · 10-20 days, repeated 1-2 times per year

NAD+ (Injectable) dosing ranges

IV anti-aging clinic protocol

500-1500 mg · Per infusion, weekly to monthly · Cycle-based

Subcutaneous wellness

50-200 mg · Daily or alternate-day · 2-4 week cycles

Intranasal

20-100 mg · Daily · Cycle-based

Epithalon vs NAD+ (Injectable) — common questions

What is the difference between Epithalon and NAD+ (Injectable)?

Epithalon: Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production. Typical dose 5000-10000 mcg. NAD+ (Injectable): Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity. Typical dose 50-200 mg (SubQ); 500-1500 mg (IV) mcg. Both fall under the Longevity category.

Can you stack Epithalon and NAD+ (Injectable)?

Stacking Epithalon with NAD+ (Injectable) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Epithalon or NAD+ (Injectable)?

Epithalon is typically dosed: Once daily (SubQ) for Anti-aging and telomere support. NAD+ (Injectable) is typically dosed: Per infusion, weekly to monthly for IV anti-aging clinic protocol; Daily or alternate-day for Subcutaneous wellness; Daily for Intranasal.

Are Epithalon and NAD+ (Injectable) FDA approved?

Epithalon: Not FDA approved for human use. No clinical trials submitted to the FDA. NAD+ (Injectable): Not FDA approved as a therapeutic. Available via compounding pharmacies for off-label use. NAD+ precursors (NR as Niagen, NMN) sold as dietary supplements.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free